{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000130","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.850040+00:00","generated_at":"2026-05-31T05:07:29.140438+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Lifecore Biomedical regains Nasdaq compliance, avoids delisting","bullets":["Filed overdue Q3 FY2023 and Q1/Q2 FY2024 10-Qs on Aug 8, 2024, and FY2024 10-K on Aug 26, 2024.","Held 2024 annual meeting on Aug 15, 2024, curing Annual Meeting Rule deficiency.","Nasdaq will monitor compliance until Sept 4, 2025; further failure to file timely could lead to delisting without cure period.","Company's common stock remains listed on The Nasdaq Global Select Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000130","json":"https://secwatch.observer/filing/0001005286-24-000130.json","markdown":"https://secwatch.observer/filing/0001005286-24-000130.md","text":"https://secwatch.observer/filing/0001005286-24-000130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000130/0001005286-24-000130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000130/lndc-20240911.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:07:29.140438+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}